P-122 LIVER TRANSIENT ELASTOGRAPHY (FIBROSCAN). FIRST REPORT OF EXPERIENCE IN ECUADOR

Introduction

Chronic liver diseases and their complications are important health problems due to their high morbidity and mortality. In Ecuador, according to INEC during 2017, cirrhosis and other liver diseases represent the seventh leading cause of death. In public hospitals liver diseases represent a significant percentage of hospital admissions, generating a significant economic impact.

In 2017 year, a private health center acquired a liver transient elastography, being the first equipment available for Ecuadorians.

Objectives

Describe the experience obtained with FibroScan, during the years 2017-2018, in a private center in the city of Quito-Ecuador.

Methods

Retrospective descriptive study. All patients attended from January 2017 to December 2018 were included. The Fibroscan touch 503 Echosens MR brand elastography equipment was used. For the classification of Fibrosis (Kp) the Fibroscan table, specified by the manufacturer, was used.

Results

During the observational period, a total of 272 procedures were performed distributed in 173 male (50 - 59 years old), and 99 female (40- 49 years old). The most frequent indication was for fatty liver (36.76%), followed by altered liver tests (31.25%). Approximately, 40.1% of patients had a BMI between 25 and 29.9 which corresponds to grade I and II overweight. Stages F0-F1 in relation to Kpa were found in 171 patients, 62.9% of the series and stages F4 in 59 patients (21.7%). A total of 37.1% of patients with S3 measured by CAP were found; of which 29% belong to the overweight and obesity groups 1. In relation to age, the stage corresponding to F4 was found in 45 (20.1%) patients aged between 50 and 89 years.

Conclusion

Non-alcoholic and alcoholic fatty liver (36.75% of our cohort) constitutes one of the most prevalent pathologies in Ecuador as a cause of chronic liver disease.

• The highest percentage of patients, 62.9%, were in Stages F0-F1, which allows a timely therapeutic intervention to prevent their progression. 21.7% were found in stage F4 (cirrhosis).

• Elastography is a non-invasive, precise, safe, easy to perform, cost-effective technique, with immediate results to estimate liver fibrosis.